857 related articles for article (PubMed ID: 26970772)
1. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
3. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
6. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S
Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695
[TBL] [Abstract][Full Text] [Related]
7. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
[TBL] [Abstract][Full Text] [Related]
9. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
[TBL] [Abstract][Full Text] [Related]
10. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
Kowada A
J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
Diel R; Lampenius N; Nienhaus A
Pharmacoeconomics; 2015 Aug; 33(8):783-809. PubMed ID: 25774015
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of concordance and costs between tuberculin skin test and QuantiFERON(®)-TB Gold In-Tube in the diagnosis of latent tuberculosis infection among contacts of patients with pulmonary tuberculosis].
Martinez Lacasa X; Canals Font R; Jaen Manzanera A; Cuchi Burgos E; Lite Lite J
Med Clin (Barc); 2015 Nov; 145(10):427-32. PubMed ID: 25794770
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
Wilson FA; Miller TL; Stimpson JP
Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
[TBL] [Abstract][Full Text] [Related]
16. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
18. Priorities for screening and treatment of latent tuberculosis infection in the United States.
Linas BP; Wong AY; Freedberg KA; Horsburgh CR
Am J Respir Crit Care Med; 2011 Sep; 184(5):590-601. PubMed ID: 21562129
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of cost and cost-effectiveness of different TB-screening strategies.
Nienhaus A; Schablon A; Costa JT; Diel R
BMC Health Serv Res; 2011 Sep; 11():247. PubMed ID: 21961888
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.
Campbell JR; Sasitharan T; Marra F
Appl Health Econ Health Policy; 2015 Aug; 13(4):325-40. PubMed ID: 26129810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]